Literature DB >> 24675078

Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.

Mahmoud El-Azzouny1, Charles R Evans, Mary K Treutelaar, Robert T Kennedy, Charles F Burant.   

Abstract

Acute fatty acid (FA) exposure potentiates glucose-stimulated insulin secretion in β cells through metabolic and receptor-mediated effects. We assessed the effect of fatty acids on the dynamics of the metabolome in INS-1 cells following exposure to [U-(13)C]glucose to assess flux through metabolic pathways. Metabolite profiling showed a fatty acid-induced increase in long chain acyl-CoAs that were rapidly esterified with glucose-derived glycerol-3-phosphate to form lysophosphatidic acid, mono- and diacylglycerols, and other glycerolipids, some implicated in augmenting insulin secretion. Glucose utilization and glycolytic flux increased, along with a reduction in the NADH/NAD(+) ratio, presumably by an increase in conversion of dihydroxyacetone phosphate to glycerol-3-phosphate. The fatty acid-induced increase in glycolysis also resulted in increases in tricarboxylic cycle flux and oxygen consumption. Inhibition of fatty acid activation of FFAR1/GPR40 by an antagonist decreased glycerolipid formation, attenuated fatty acid increases in glucose oxidation, and increased mitochondrial FA flux, as evidenced by increased acylcarnitine levels. Conversely, FFAR1/GPR40 activation in the presence of low FA increased flux into glycerolipids and enhanced glucose oxidation. These results suggest that, by remodeling glucose and lipid metabolism, fatty acid significantly increases the formation of both lipid- and TCA cycle-derived intermediates that augment insulin secretion, increasing our understanding of mechanisms underlying β cell insulin secretion.

Entities:  

Keywords:  Diabetes; Fatty Acid Metabolism; Fatty Acid Potentiation of GSIS; G Protein-coupled Receptors (GPCR); GPR40; Glucose Metabolism; Insulin Secretion; Metabolism; Metabolomics; β Cell

Mesh:

Substances:

Year:  2014        PMID: 24675078      PMCID: PMC4036363          DOI: 10.1074/jbc.M113.531970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance.

Authors:  Edwin P Kwan; Li Xie; Laura Sheu; Christopher J Nolan; Marc Prentki; Andrea Betz; Nils Brose; Herbert Y Gaisano
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

2.  Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion.

Authors:  Blanca Rubí; Peter A Antinozzi; Laura Herrero; Hisamitsu Ishihara; Guillermina Asins; Dolors Serra; Claes B Wollheim; Pierre Maechler; Fausto G Hegardt
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

3.  Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion.

Authors:  M Prentki; S Vischer; M C Glennon; R Regazzi; J T Deeney; B E Corkey
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

4.  Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion.

Authors:  Laura Herrero; Blanca Rubí; David Sebastián; Dolors Serra; Guillermina Asins; Pierre Maechler; Marc Prentki; Fausto G Hegardt
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

5.  Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing.

Authors:  N Sekine; V Cirulli; R Regazzi; L J Brown; E Gine; J Tamarit-Rodriguez; M Girotti; S Marie; M J MacDonald; C B Wollheim
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate.

Authors:  S M Parker; P C Moore; L M Johnson; V Poitout
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

7.  Long-chain CoA esters activate human pancreatic beta-cell KATP channels: potential role in Type 2 diabetes.

Authors:  R Bränström; C A Aspinwall; S Välimäki; C-G Ostensson; A Tibell; M Eckhard; H Brandhorst; B E Corkey; P-O Berggren; O Larsson
Journal:  Diabetologia       Date:  2004-01-23       Impact factor: 10.122

Review 8.  The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?

Authors:  Arturo D Mancini; Vincent Poitout
Journal:  Trends Endocrinol Metab       Date:  2013-04-27       Impact factor: 12.015

9.  Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.

Authors:  Hindrik Mulder; Shumin Yang; Maria Sörhede Winzell; Cecilia Holm; Bo Ahrén
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

10.  A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli.

Authors:  Raphaël Roduit; Christopher Nolan; Cristina Alarcon; Patrick Moore; Annie Barbeau; Viviane Delghingaro-Augusto; Ewa Przybykowski; Johane Morin; Frédéric Massé; Bernard Massie; Neil Ruderman; Christopher Rhodes; Vincent Poitout; Marc Prentki
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  30 in total

Review 1.  Nutrition and metabolic correlates of obesity and inflammation: clinical considerations.

Authors:  Amy R Johnson; Liza Makowski
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 2.  Connecting pancreatic islet lipid metabolism with insulin secretion and the development of type 2 diabetes.

Authors:  Yumi Imai; Ryan S Cousins; Siming Liu; Brian M Phelps; Joseph A Promes
Journal:  Ann N Y Acad Sci       Date:  2019-04-02       Impact factor: 5.691

Review 3.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

Review 4.  Metabolomics and Metabolic Diseases: Where Do We Stand?

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

5.  Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly.

Authors:  Mahmoud ElAzzouny; Christopher T M B Tom; Charles R Evans; Lori L Olson; Mary J Tanga; Katherine A Gallagher; Brent R Martin; Charles F Burant
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

6.  Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.

Authors:  Saleem Yousf; Devika M Sardesai; Abraham B Mathew; Rashi Khandelwal; Jhankar D Acharya; Shilpy Sharma; Jeetender Chugh
Journal:  Metabolomics       Date:  2019-03-29       Impact factor: 4.290

Review 7.  Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion.

Authors:  William T Moore; Suzanne M Bowser; Dane W Fausnacht; Linda L Staley; Kyung-Shin Suh; Dongmin Liu
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 8.  Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Authors:  Michael A Kalwat; Melanie H Cobb
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

Review 9.  Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.

Authors:  G R Kolar; S M Grote; G L C Yosten
Journal:  J Intern Med       Date:  2016-06-16       Impact factor: 8.989

10.  Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.

Authors:  Jessica R Gooding; Mette V Jensen; Xiaoqing Dai; Brett R Wenner; Danhong Lu; Ramamani Arumugam; Mourad Ferdaoussi; Patrick E MacDonald; Christopher B Newgard
Journal:  Cell Rep       Date:  2015-09-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.